PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Blue Cross & Blue Shield of MississippiCommercial · Coverage · Pharmacy · MS · Neurology, PharmacyMedium impact

State and School Employees' Health Insurance Plan - ACTH Gel (Repository Corticotropin Injection)

Effective date
Not stated in the notice
Identified
Jun 20, 2026

Summary

Repository corticotropin injection (H.P. Acthar Gel) may be considered medically necessary for the treatment of infantile spasms (West syndrome). It is considered investigational for diagnostic testing of adrenocortical function, for corticosteroid-responsive conditions unless there are medical contraindications or intolerance to corticosteroids that are not also expected with this injection, and for conditions not responsive to corticosteroid therapy, including tobacco cessation, acute gout and childhood epilepsy. Services related to delivery or administration of a medication determined to be not medically necessary are also considered not medically necessary, and the most recent policy history entry, dated 01/10/2025, states the policy was reviewed with no changes.

Get alerts when payers change rules like this one

We check Blue Cross & Blue Shield of Mississippi and other payers every day and email you when a change matches your specialty and state.

Get Blue Cross & Blue Shield of Mississippi alertsPolicy Monitoring is free. No card required.

What to do

Action · 3 steps
01Billing team: Perform a search of the State Health Plan Medical Drug Formulary for drugs administered and billed through the medical setting before billing this drug.
02Billing team: For use in corticosteroid-responsive conditions, the record must document medical contraindications or intolerance to corticosteroids that are not also expected to occur with this injection, since otherwise the use is considered investigational.
03Billing team: For Federal Employee Program members, the policy notes that FEP may dictate that FDA-approved drugs may not be considered investigational and may be assessed only on the basis of medical necessity.

Codes mentioned

96372G40.821G40.824

Original notice

State and School Employees' Health Insurance Plan - ACTH Gel (Repository Corticotropin Injection)
bcbsms.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account